A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Conferences AACR 2019: Single agent umbralisib effective for relapsed slow-growing lymphoma April 8, 2019 A study at The University of Texas MD Anderson Cancer Center revealed the investigational drug…